Synthetic retinoids as potential antitumour agents

Bibliography

• ALTUCCI L, GRONEMEYER H: The promise of retinoids to fight against cancer. Nat. Rev. (2001) 1:181-193. An excellent review of retinoids in antitumour therapy.
   Google Scholar
• CLARKE N, GERMAIN P, ALTUCCI L et al.: Retinoids: potential in cancer prevention and therapy. Expert Rev. Mol. Med. (2004) 6:1–23.
   PubMedGoogle Scholar
• ZHANG X-K: Vitamin A and apoptosis in prostate cancer. Endocr. Relat. Cancer (2002) 9:87–102.
   PubMed Web of Science ®Google Scholar
• GARATTINI E, GIANNI M, TERAO M: Retinoid related molecules, an emerging class of apoptotic agents with promising clinical potential in oncology: pharmacological activity and mechanisms of action. Curr. Pharm. Des. (2004) 10:433-448. A comprehensive review of the mechanisms of retinoid-induced apoptosis.
   Google Scholar
• FONTANA JA, RISHI AK: Classical and novel retinoids: their targets in cancer therapy. Leukemia (2002) 16:463-472. An excellent review of retinoids.
   Google Scholar
• MEHTA K: Retinoids as regulators of gene transcription. J. Biol. Regul Homeost. Agents (2003) 17:1–12.
   PubMed Web of Science ®Google Scholar
• LOTAN R: Receptor-independent induction of apoptosis by synthetic retinoids. J. Biol. Regul Homeost. Agents (2003) 17:13-28. An excellent review of the mechanism of apoptosis induction.
   Google Scholar
• SCHADENDORF D, KERN MA, ARTUC M et al.: Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell. Biol. (1996) 135:1889–1898.
   PubMed Web of Science ®Google Scholar
• LUX-P, FANJUL A, PICARD N et al.: Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med. (1997) 3:686–690.
   PubMed Web of Science ®Google Scholar
• CINCINELLI R, DALLAVALLE S, MERLINI Let al.: A novel atypical retinoid endowed with proapoptotic and antitumor activity. J. Med. Chem. (2003) 46:909–912.
   Google Scholar
• PISANO C, MERLINI L, PENCO S, CARMINATI P, ZUNINO F: Cellular and pharmacological bases of the antitumor activity of a novel adamantyl retinoid, ST1926.1 Chemother. (2004) 16:74–76.
   PubMed Web of Science ®Google Scholar
• BERNARD BA, BERNARDON J-M, DELESCLUSE C et al.: Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor y. Biochem. Biophys. Res. Comm. (1992) 186:977–983.
   PubMed Web of Science ®Google Scholar
• SHAO Z-M, DAWSON MI, LI X-S et al.: P53 independent GI/G, arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene (1995) 11:493–504.
   PubMed Web of Science ®Google Scholar
• SUN S-Y, YUE P, SHROOT B, HONG WK, LOTAN R: Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437./ Cell Physiol (1997) 173:279–284.
   PubMed Web of Science ®Google Scholar
• ORIDATE N, HIGUCHI M, SUZUKI S et al.: Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 643-(1-aciamanty1)-4-hydroxypheny1]-2-naphtalene carboxylic acid (CD437). Int. J. Cancer (1997) 70:484–487.
   PubMedGoogle Scholar
• PIEDRAFITA FJ, PFAHL M: Retinoid-induced apoptosis and Apl cleavage occur independently of transcription and require caspase activation. Mol. Cell. Biol. (1997) 17:6348–6358.
   PubMed Web of Science ®Google Scholar
• BROWN JM, ATTARDI LD: The role of apoptosis in cancer development and treatment response. Nat. Rev. (2005) 5:231–237.
   Google Scholar
• HERR I, DEBATIN K-M: Cellular stress response and apoptosis in cancer therapy. Blood (2001) 98:2603–2614.
   PubMed Web of Science ®Google Scholar
• BLAGOSKLONNY MV: Prospective strategies to enforce selectively cell death in cancer cells. Oncogene (2004) 23:2967–2975.
   PubMed Web of Science ®Google Scholar
• ORTIZ MA, BAYON Y, LOPEZ -HERNANDEZ FJ et al.: Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist. Updat. (2002) 5:162–175.
   Google Scholar
• ALTUCCI L, GRONEMEYER H: Retinoids and TRAIL: two cooperating actors to fight against cancer. Vitam. Horm. (2004) 67:319–345.
   PubMed Web of Science ®Google Scholar
• PFAHL M, PIEDRAFITA FJ: Retinoid targets for apoptosis induction. Oncogene (2003) 22:9058–9062.
   PubMed Web of Science ®Google Scholar
• SHEIKH MS, SHAO ZM, LI XS et al.: N-(4-hydroxyphenyl) retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis (1995) 16:2477–2486.
   PubMed Web of Science ®Google Scholar
• TORRISI R, DECENSI A: Fenretinide andcancer prevention. Curr. Oncol. Rep. (2000) 2:262–270.
   Google Scholar
• CHIESA F, TRADATI N, MARAZZA M et al.: Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Oral Oncol Eur. J. Cancer (1992) 288:97–102.
   Google Scholar
• CHUN K-H, PFAHL M, LOTAN R: Induction of apoptosis by the synthetic retinoid MX3350-1 through extrinsic and intrinsic pathways in head and neck squamous carcinoma cells. Oncogene (2005) 24:3669–3677.
   PubMed Web of Science ®Google Scholar
• KEEDWELL RG, ZHAO Y, HAMMOND LA et al.: A retinoid-related molecule that does not bind to classical retinoid receptors potently induces apoptosis in human prostate cancer cells through rapid caspase activation. Cancer Res. (2004) 64:3302–3312.
   PubMed Web of Science ®Google Scholar
• SUN SY, YUE P, SHROOT B et al.: Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells. Oncogene (1999) 18:3894–3901.
   PubMed Web of Science ®Google Scholar
• SUN SY, YUE P, WI] GS et al.: Implicationof p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res. (1999) 59:2829–2833.
   Google Scholar
• BRENNER C, KROEMER G: Mitochondria - the death signal integrators. Science (2000) 289:1150–1151.
   PubMed Web of Science ®Google Scholar
• MARCHETTI P, ZAMZAMI N, JOSEPH B et al.: The novel retinoid 643-(1-adamanty1)-4-hydroxyphenyll -2-naphthalenecarboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res. (1999) 59:6257–6266.
   PubMed Web of Science ®Google Scholar
• CHUN K-H, BENBROOK DM, BERLIN KD et al.: The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res. (2003) 63:3826–3832.
   PubMed Web of Science ®Google Scholar
• PALISSOT V, MORJANI H, BELLOC F et al.: From molecular characteristics to cellular events in apoptosis-resistant HL-60 cells. Int. J. OncoL (2005) 26:825–834.
   PubMed Web of Science ®Google Scholar
• SCHWEYER S, SORURI A, HEINTZE A et al.: The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Int. J. OncoL (2004) 25:1671–1676.
   PubMed Web of Science ®Google Scholar
• DAWSON MI, HARRIS DL, LIU G et al.:Antagonist analogue of 6-43'41-adamanty1)-4'-hydroxyphenyll -2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest. J. Med. Chem. (2004) 47:3518–36.
   PubMed Web of Science ®Google Scholar
• ZUCO V, ZANCHI C, CASSINELLI G et al.: Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid. Cell Death Duff (2004) 11:280–289.
   PubMed Web of Science ®Google Scholar
• •First publication describing genotoxic damage by an adamantyl retinoid.
   Google Scholar
• ARNOULT D, PARONE P, MARTINOU J-C et al.: Mitochomirial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell. Biol. (2002) 159:923–929.
   PubMed Web of Science ®Google Scholar
• HOLMES WF, SOPRANO DR, SOPRANO KJ: Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene (2003) 22:6377–6386.
   PubMed Web of Science ®Google Scholar
• HOLMES WF, SOPRANO DR, SOPRANO KJ: Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell CelL PhysioL (2004) 199:317–329.
   Google Scholar
• ZUCO V, ZANCHI C, LANZI C et aL: Development of resistance to the atypical retinoid, 5T1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response. Neop/asia (2005) 7:667–77
   PubMed Web of Science ®Google Scholar
• NORBURY CJ, ZHIVOTOVSKY B: DNA damage-induced apoptosis. Oncogene (2004) 23:2797–2808.
   PubMed Web of Science ®Google Scholar
• MARTINDALE JL, HOLBROOK NJ: Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. PhysioL (2002) 192:1–15.
   PubMed Web of Science ®Google Scholar
• SIDDIK ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene (2003) 22:7265–7279.
   PubMed Web of Science ®Google Scholar
• ORTIZ MA, LOPEZ-HERNANDEZ FJ, BAYON Y, PFAHL M, PIEDRAFITA FJ: Retinoid-related molecules induce cytochrome c release and apoptosis through activation of c-Jun NH2-terminal kinase/ p38 mitogen-activated protein kinases. Cancer Res. (2001) 61:8504–8512.
   PubMed Web of Science ®Google Scholar
• BAYON Y, ORTIZ MA, LOPEZ -HERNANDEZ FJ et al.: Inhibition of IKB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. MoL Cell. BioL (2003) 23:1061–1074.
   Google Scholar
• FARHANA L, DAWSON MI, FONTANA JA: Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-KB activation. Cancer Res. (2005) 65:4909–4917.
   PubMed Web of Science ®Google Scholar
• ORLOWSKI RZ, BALDWIN AS: NF-KB as a therapeutic target in cancer. Trends MoL Med. (2002) 8:385–389.
   PubMed Web of Science ®Google Scholar
• ZANCHI C, ZUCO V LANZI C et aL: Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid 5T1926 and the epidermal growth factor receptor inhibitor ZD1839. Cancer Res. (2005) 65:2364–2372.
   PubMed Web of Science ®Google Scholar
• •Publication showing evidence of a correlation between genotoxic stress and apoptosis.
   Google Scholar
• ZHAO X, SPANJAARD RA: The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis . J. Biomed Sci. (2003) 10:44–49.
   PubMed Web of Science ®Google Scholar
• LOSA JH, COBO CP, VINIEGRA JG et al.: Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene (2003) 22:3998–4006.
   PubMed Web of Science ®Google Scholar
• LIU S, BROWN CW, BERLIN KD et al.: Synthesis of flexible sulphur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malingant and benign cells. J. Med. Chem. (2004) 47:999–1007.
   PubMed Web of Science ®Google Scholar
• BENBROOK DM, MADLER MM, SPRUCE Let al.: Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity. J. Med. Chem. (1997) 40:3567–3583.
   Google Scholar
• DHAR A, LIU S, KLUCIK J et ell.: Synthesis, structure-activity relationships, and RARy-ligand interactions of nitrogen heteroarotinoids. J. Med. Chem. (1999) 42:3602–3614.
   Google Scholar
• ZACHEIS D, DHAR A, LU S et al.: Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both BAR and RXR retinoic acid receptors. J. Med. Chem. (1999) 42:4434–4445.
   PubMed Web of Science ®Google Scholar
• TENG M, DUONG TT, KLEINS ES et al.: Identification of a retinoic acid receptor a subtype specific agonist. J. Med. Chem. (1996) 39:3035–3038.
   PubMed Web of Science ®Google Scholar
• BOEHM MF, ZHANG L, ZHI L et aL: Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. (1995) 38:3146–3145.
   PubMed Web of Science ®Google Scholar
• NAKAGAWA S, FUJII T, YOKOYAMA G et al.: Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: involvement of protein kinase Ca and extracellular signal-regulated kinase mitogen-activated protein kinase. MoL Carcinog (2003) 38:106–116.
   PubMed Web of Science ®Google Scholar
• WANG Q, LEE D, SYSOUNTHONE V et al.: 1,25-Dihydroxyvitamin D, and retinoic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res. Treat. (2001) 67:157–168.
   PubMed Web of Science ®Google Scholar
• TANOSAKI S, IKEZOE T, HEANEY A et al.: Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res. Treat. (2003) 79:335–345.
   PubMed Web of Science ®Google Scholar
• CROWE DL, KIM R, CHANDRARATNA RAS: Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res. (2003) 1:532–540.
   PubMed Web of Science ®Google Scholar
• SCHALER M, LIEBLER S, SCHADE K et al.: Retinoic acid receptor a and X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the RAR. J. Mo/. Med. (2004) 82:116–125.
   PubMed Web of Science ®Google Scholar
• HALLAHAN AR, PRITCHARD JI, CHANDRARATNA RAS et al: BPM-2 mediates retinoid-induced apoptosis in medulloblastoma cells thorugh a paracrine effect. Nat. Med. (2003) 9:1033–1038.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, DAWSON MI, MOHAMMED R et al.: Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog. Blood (2002) 100:2917–2925.
   PubMed Web of Science ®Google Scholar
• FARHANA L, DAWSON MI, FONTANA JA: Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-KB activation. Cancer Res. (2005) 65:4909–4917.
   PubMed Web of Science ®Google Scholar
• PHILLIPS TJ: An update on the safety andefficacy of topical retinoids. Cutts (2005) 75:14–22.
   PubMed Web of Science ®Google Scholar
• CINCINELLI R, DALLAVALLE S, NANNEI R et al.: Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-yl-acrylic acids endowed with antiproliferative and proapoptotic activity. J. Med. Chem. (2005) 48:4931–4946.
   PubMed Web of Science ®Google Scholar
• HAMMOND LA, BROWN G, KEEDWELL RG et al: The prospects of retinoids in the treatment of prostate cancer. Anticancer Drugs (2002) 13:781–790.
   PubMed Web of Science ®Google Scholar
• DAWSON MI: Synthetic retinoids and their nuclear receptors. Curr. Med. Chem. Anticancer Agents (2004) 4:199–230.
   PubMedGoogle Scholar
• KAGECHIKA H, SHUDO K: Synthetic retinoids: recent developments concerning structure and clinical utility. J. Med. Chem. (2005) 48:1–9.
   PubMed Web of Science ®Google Scholar
• FANJUL AN, PIEDRAFITA FJ, AL-SHAMMA H, PFAHL M: Apoptosis induction and potent antiestrogen receptor - negative breast cancer activity in vivo by a retinoid antagonist. Cancer Res. (1998) 58:4607–4610.
   PubMed Web of Science ®Google Scholar